Evidence map›Paper›PMID 41828697›Full record

ArticleInternational journal of molecular sciences2026

The Critical Role of Adenylate Kinase in Regulating the Glycolysis Rate in Cells.

Michael V Martinov, Fazoil I Ataullakhanov, Victor M Vitvitsky

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael V MartinovCenter for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
Fazoil I AtaullakhanovCenter for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
Victor M VitvitskyCenter for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.ORCID 0000-0001-6251-6115

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of adenylate kinase in regulating the glycolysis rate and the potential contribution of the adenylate kinase reaction to ATP production were examined using mathematical models of energy metabolism in human erythrocytes and resting anaerobic mammalian skeletal muscle. The adenylate kinase reaction was shown to play a critical role in the regulation of cellular energy metabolism. Through the action of adenylate kinase, small changes in intracellular [ATP] give rise to large changes in [AMP], a potent activator of glycolytic flux via the activation of phosphofructokinase (PFK). This mechanism ensures an increase in the glycolytic rate as [ATP] decreases within the physiological range of ATP concentrations. As a result, negative feedback regulation of glycolysis by [ATP] is established, allowing the rate of ATP production to adjust to the energy demands of the cell and thereby stabilizing [ATP] under varying rates of ATP consumption. Importantly, allosteric inhibition of PFK by ATP alone was insufficient to provide negative feedback regulation of glycolysis via [ATP]. The contribution of the adenylate kinase reaction to ATP production appears to be negligible. Also, due to the presence of adenylate kinase in cells, energy metabolism is regulated not by the absolute concentration of ATP, but by the energy charge or the ratio of [ATP] to the sum of [ATP], [ADP], and [AMP].

Indexed as

Adenylate KinaseGlycolysisAdenosine TriphosphateAnimalsEnergy MetabolismErythrocytesHumansModels, BiologicalMuscle, SkeletalAdenosine TriphosphateAdenylate Kinaseadenylate kinaseerythrocyteglycolysismathematical modelingmuscle

Identifiers

PMID41828697
PMCPMC12985941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.